S. T. Disale et al. / Tetrahedron Letters 53 (2012) 2277–2279
2279
(k) Gallardo-Macias, R.; Nakayama, K. Synthesis 2010, 1, 57; (l) Akiyama, T.;
Sanada, M.; Fuchibe, K. Synlett 2003, 1463; (m) Manabe, K.; Kobayashi, S. Chem.
Commun. 2000, 669; (n) Ha, H. J.; Nam, G. S. Synth. Commun. 1992, 22, 1143.
11. Kabachnik, M. M.; Zobnina, E. V.; Beletskaya, I. P. Synlett 2005, 1393.
12. Xia, M.; Lu, Y. D. Ultrason. Sonochem. 2007, 14, 235.
13. Yadav, J. S.; Reddy, B. V. S.; Sreedhar, P. Green Chem. 2002, 4, 436.
14. (a) Ramachari, D. B.; Kishor, M. J. Org. Chem. 2007, 72, 5056; (b) Yadav, L. D. S.;
Singh, S.; Rai, V. K. Green Chem. 2009, 72, 5056; (c) Leitner, W. Green Chem.
2009, 11, 603.
Cl2Zn
H
N
O
OC2H5
OC2H5
P
O
H
H2N
+
ChCl 2 ZnCl2
-H2O
15. Abbott, A. P.; Capper, G.; Davies, D. L.; Munro, H.; Rasheed, R. K.; Tambyrajah, V.
Chem. Commun. 2001, 2010.
16. Abbott, A. P.; Capper, G.; Davies, D. L.; Munro, H.; Rasheed, R. K. Inorg. Chem.
2004, 43, 3447.
17. Abbott, A. P.; Capper, G.; Davies, D. L.; Rasheed, R. K.; Tambyrajah, V. Green
Chem. 2002, 4, 24.
Cl2Zn
N
N
H
18. Morales, R. C.; Tambyrajah, V.; Jenkins, P. R.; Davies, D. L.; Abbott, A. P. Chem.
Commun. 2004, 158.
Cl2Zn
19. Abbott, A. P.; Bell, T. J.; Handa, S.; Stoddart, B. Green Chem. 2005, 7, 705.
20. Duan, Z.; Gu, Y.; Deng, Y. Cat. Commun. 2006, 7, 651.
N
H+
OC2H5
OC2H5
21. (a) Parghi, K. D.; Jayaram, R. V. Green Chem. Lett. Rev. 2011, 4, 14, 3–9.; (b)
Parghi, K. D.; Jayaram, R. V. Catal. Commun. 2010, 11, 1205–1210; (c)
Shrikhande, J. J.; Gawande, M. B.; Jayaram, R. V. Tetrahedron Lett. 2008, 49,
4799–4803; (d) Singh, S. J.; Jayaram, R. V. Tetrahedron Lett. 2008, 49, 4249–
4251; (e) Gawande, M. B.; Polshettiwar, V.; Varma, R. S.; Jayaram, R. V.
Tetrahedron Lett. 2007, 48, 8170–8173.
P
O
Cl2Zn
N
Ch Cl2Zn
OH
Cl
H
:
P
OC2H5
22. Cherkasov, R. A.; Galkina, I. V. Russ. Chem. Rev. 1998, 67, 85.
OC2H5
23. All of the
a-aminophosphonates are known compounds to which the
spectroscopic data were compared.
Table 2, 4a: 31P NMR (120 MHz, CDCl3): d = 21.066. 1H NMR (300 MHz, CDCl3):
d = 1.08–1.14 (t, 3H, –OCH2CH3), 1.25–1.31(t, 3H, –OCH2CH3), 3.6–3.72 (m, 1H,
–OCH2CH3), 3.87–3.98 (m, 1H, –OCH2CH3), 4.02–4.18 (m, 2H, –OCH2CH3), 4.72
(d, 1H, CH), 4.8 (s, 1H, NH), 6.59 (d, 2H, C6H5), 6.68(t, 1H, C6H5), 7.10 (t, 2H,
C6H5), 7.24–7.36 (m,3H, C6H5),7.44–7.49 (d, 2H, C6H5). GC–MS (m/z): 319 (M+),
182 (100), 167, 152, 104, 77, 51.
O
P
OC2H5
OC2H5
H
Table 2, 4b: 31P NMR (120 MHz, CDCl3): d = 20.188. 1H NMR (300 MHz, CDCl3):
d = 1.12–1.19 (t, 3H, –OCH2CH3), 1.25–1.33 (t, 3H, –OCH2CH3), 3.72–3.84, 3.92–
4.02, 4.04–4.18 (m, 4H, –OCH2CH3),4.67 (d, 1H, CH), 4.78 (s, 1H, NH), 6.57 (d,
2H, C6H4, C6H5), 6.73 (t, 1H, C6H4,C6H5), 7.08–7.26 (m, 3H, C6H4, C6H5),7.37–
7.42(m, 2H, C6H5, C6H4),7.7 (d, 1H, C6H4, C6H5). GC–MS (m/z): 399,397 (M+),
262, 260 (100), 182,180, 152, 104, 77, 45.
Scheme 2. Plausible mechanism.
conditions, considerably short reaction time, high yields, reusabil-
ity of the catalyst, and cost effectiveness make this protocol an
Table 2, 4d: 31P NMR (120 MHz, CDCl3) d = 20.197. 1H NMR (300 MHz, CDCl3):
d = 1.12–1.20 (t, 3H, –OCH2CH3),1.27–1.33(t, 3H, OCH2CH3), 3.72–3.84, 3.92–
4.04,4.06–4.2 (m, 4H, –OCH2CH3), 4.68 (d, 1H, CH), 4.76 (s, 1H, NH), 6.57 (d, 2H,
C6H5, C6H4), 6.74 (t, 1H, C6H5, C6H4),7.13 (t, 2H, C6H5, C6H4), 7.24–7.48 (m, 4H,
C6H5, C6H4).
important addition to the existing methods of
a-aminophospho-
nate synthesis. Further work is in progress to broaden the scope
of choline chloride based moisture stable ionic liquids to the other
organic transformations.
GC–MS (m/z): 353(M+), 216 (100), 180, 104, 77, 51.
Table 2, 4e: 31P NMR (120 MHz, CDCl3): d = 21.284. 1H NMR (300 MHz, CDCl3):
d = 1.03–1.17 (t, 3H,–OCH2CH3), 1.25–1.32 (t, 3H,–OCH2CH3), 3.78 (s, 3H, CH3),
3.62–3.74, 3.88–3.98, 4.01–4.18 (m, 4H, –OCH2CH3), 4.66 (d, 1H, CH), 4.73 (s,
1H, NH), 6.58–6.62 (d, 3H, C6H4, C6H5), 6.66–7.4 (m, 6H, C6H4,C6H5). GC–MS
(m/z): 349 (M+), 212,195, 168, 134, 111, 104, 77, 51.
Acknowledgment
Table 2, 4g: 31P NMR (120 MHz, CDCl3): d = 20.197. 1H NMR (300 MHz, CDCl3):
d = 1.14–1.20 (t, 3H, –OCH2CH3), 1.26–1.33(t, 3H,–OCH2CH3), 3.72–3.86, 3.93–
4.21 (m, 4H, –OCH2CH3), 4.68 (d, 1H, CH), 4.78 (s, 1H, NH), 6.64 (d, 2H, C6H5,
C6H4), 6.72 (t, 1H, C6H4, C6H5), 7.12 (t, 2H, C6H5, C6H4), 7.32–7.38 (m, 2H, C6H5,
C6H4), 7.47(d, 2H, C6H5, C6H4). GC–MS (m/z): 399, 397 (M+), 262, 260 (100),
180, 182, 104, 77, 51.
Financial assistance from the Indira Gandhi Center for Atomic
Research (IGCAR) is gratefully acknowledged.
References and notes
Table 2, 4j: 31P NMR (120 MHz, CDCl3): d = 20.915. 1H NMR (300 MHz, CDCl3):
d = 1.08–1.15 (t, 3H,–OCH2CH3), 1.25–1.32 (t, 3H, OCH2CH3), 3.6–3.74, 3.88–
3.98, 4.04–4.18 (m, 4H,–OCH2CH3), 4.64 (d, 1H, CH), 4.71 (s, 1H, NH), 6.5–6.54
(m, 2H, C6H5,C6H4), 6.76–6.84 (m,2H, C6H5, C6H4), 7.24–7.44(m, 5H, C6H5,C6H4).
Table 2, 4n: 31P NMR (120 MHz, CDCl3): d = 20.887. 1H NMR (300 MHz, CDCl3):
d = 1.09–1.17 (t, 3H, –OCH2CH3), 1.26–1.32 (t, 3H, –OCH2CH3), 3.78 (s, 3H, CH3),
3.61–3.72, 3.88–3.98, 4.04–4.18 (m, 4H, –OCH2CH3),4.62 (d, 1H), 6.4 (d,2H,
C6H4, C6H5),6.86 (d, 2H, C6H4, C6H5), 7.18–7.36(m, 2H, C6H5). GC–MS (m/z):
427,429 (M+), 291, 293, 275, 247, 249, 211, 183, 181, 157, 155, 109, 65, 44.
Catalyst preparation: In this study, the ionic liquids used were synthesized
according to the procedure reported in the literature.15
1. Peyman, A.; Budt, K. H.; Paning, J. S.; Stowasser, B.; Ruppert, D. Tetrahedron Lett.
1992, 33, 4549.
2. Alonso, E.; Solis, A.; Del Pozo, C. Synlett 2000, 698.
3. Allerberger, F.; Klare, I. J. J. Antimicrob. Chemother. 1999, 43, 211.
4. Maier, L. Phosphorus, Sulfur Silicon Relat. Elem. 1990, 47, 43.
5. Maier, L.; Sporri, H. Phosphorus, Sulfur Silicon Relat. Elem. 1991, 61, 69.
6. Emsley, J.; Hall, D. Chemistry of Phosphorus; Harper & Row: London, 1976. pp
494.
7. Chung, S. K.; Kang, D. H. Tetrahedron: Asymmetry 1996, 7, 21.
8. Kafarski, P.; Lejczak, B. Phosphorus, Sulfur Silicon Relat. Elem. 1991, 63, 193.
9. (a) Kabachnik, M. J.; Medved, T. Izv. Akad. Nauk SSSR 1953, 1126; (b) Kabachnik,
M. J.; Medved, T. Izv. Akad. Nauk SSSR 1954, 1024; (c) Fields, E. K. J. Am. Chem.
Soc. 1952, 74, 1528.
10. (a) Qian, C.; Huang, T. J. Org. Chem. 1998, 63, 4125; (b) Paraskar, A. S.; Sudalai, A.
Arkivok 2006, 183; (c) Ranu, B. C.; Hajra, A.; Jana, U. Org. Lett. 1999, 1, 1141; (d)
Xu, F.; Luo, Y.; Deng, M.; Shen, Q. Eur. J. Org. Chem. 2003, 4728; (e) Zon, J. Pol. J.
Chem. 1981, 55, 643; (f) Laschat, S.; Kunz, H. Synthesis 1992, 90; (g)
Chandrasekhar, S.; Prakash, S. J.; Jagadeshwar, V.; Narsihmulu, C. Tetrahedron
Lett. 2001, 42, 5561; (h) Kaboudin, B.; Nazari, R. Tetrahedron Lett. 2001, 42,
8211; (i) Bhagat, S.; Chakraborti, A. K. J. Org. Chem. 2007, 72, 1263; (j) Heydari,
A.; Zarei, M.; Alijanianzadeh, R.; Tavakol, H. Tetrahedron Lett. 2001, 42, 3629;
Typical experimental procedure: To
a stirred mixture of benzaldehyde
(2.0 mmol), amine (2.0 mmol), and dialkyl phosphite (2.0 mmol), ChClÁ2ZnCl2
(15 mol %) was added. The reaction mixture was stirred at rt for the time
indicated in Table 2 (progress of the reaction was followed by TLC). The
product formed was extracted with MTBE (2 Â 5 mL). The solid product
obtained after concentrating the combined ether extract on rotary evaporator
was further washed with sodium metabisulphite solution (2 Â 5 mL) and
hexane (2 Â 5 mL) to give pure product. The remaining viscous ionic liquid was
further washed with MTBE and dried at 80 °C to retain its catalytic activity.